IP Library Patent Application 13963858
Patent Application
App. No. 13/963,858

Micoorganisms and Methods for the Production of Fatty Acids and Fatty Acid Derived Products

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/963,858
Abstract

This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism

Claims (15)

1 . A genetically modified microorganism producing a fatty acid or fatty acid derived product, wherein the fatty acid chain length can be selected from 4 to >18, wherein fatty acids are produced via a growing fatty acyl-CoA chain and wherein additionally, the fatty acid chain is extended with at least one malonyl-CoA molecule and without the use of malonyl-ACP.

2 . A genetically modified microorganism of claim 1 , wherein the butyryl-CoA product/intermediate is made from acetyl-CoA and malonyl-CoA.

3 . A genetically modified microorganism of claim 1 , wherein the butyryl-CoA product/intermediate is made from malonyl-CoA.

4 . A genetically modified microorganism of claim 1 , wherein an acyl-CoA (length n) product/intermediate with chain length greater than 4 is made from acetyl-CoA and an acyl-CoA chain (length n−2).

5 . A genetically modified microorganism of claim 1 , wherein an acyl-CoA (length n) product/intermediate with chain length greater than 4 is made from malonyl-CoA and an acyl-CoA chain (length n−2).

6 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C4 and wherein the C4 chain comprises >9%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

7 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C6 and wherein the C6 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

8 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C8 and wherein the C8 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

9 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C10 and wherein the C10 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

10 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C12 and wherein the C12 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

11 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C14 and wherein the C14 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

12 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C16 and wherein the C16 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

13 . A genetically modified microorganism of claim 1 , wherein the product is a fatty acid mixture enriched for chain length C18 and wherein the C18 chain comprises >10%, >50%, >85% or >95% percentage of the total fatty acid product on mass (g) basis.

14 . A fermentation process using an microorganism from any of the above claims, wherein a fatty acid or fatty acid based product is produced.

15 . A genetically modified microorganism of any of the above claims, wherein the microorganism is further genetically modified to convert an acyl-CoA into a fatty acid derived product, including an alcohol, aldehyde, alkene, alkane or diacid.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2016
From: SILICON VALLEY BANK
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 040746/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2015
From: LYNCH, MICHAEL D
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 036935/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2015
From: OPX BIOTECHNOLOGIES, INC.
To: CARGILL, INCORPORATED
Reel/Frame 037022/0806 →
SECURITY INTEREST Recorded Apr 7, 2015
From: OPX BIOTECHNOLOGIES, INC.
To: SILICON VALLEY BANK
Reel/Frame 035350/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: LIAO, HANS; SPINDLER, EILEEN; LOUIE, MICHAEL; RIBBLE, WENDY; PRATHER, BRITTANY; EVANS, RON; LIPSCOMB, TANYA E.W.; WARNER, JOSEPH R.
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 031084/0191 →